Cost effectiveness of recombinant human insulin-like growth factor I therapy in patients with ALS

Ackerman, S.J.; Sullivan, E.M.; Beusterien, K.M.; Natter, H.M.; Gelinas, D.F.; Patrick, D.L.
February 1999
PharmacoEconomics;1999, Vol. 15 Issue 2, p179
Academic Journal
journal article
Objective: Amyotrophic lateral sclerosis (ALS) is a fatal, degenerative neuromuscular disease characterised by a progressive loss of voluntary motor activity. Recombinant human insulin-like growth factor I (rhIGF-I) has been shown to be useful in treating ALS. The purpose of this study was to examine the cost effectiveness of rhIGF-I therapy in patients who have ALS.Design: We performed a cost-effectiveness analysis from the societal perspective on 177 patients who received treatment with rhIGF-I or placebo in a North American randomised clinical trial. We estimated the incremental cost-effectiveness ratio of rhIGF-I using resource utilisation and functional status measurements from the clinical trial. Costs were estimated from 1996 US Medicare reimbursement schedules. Utility weights were elicited from ALS healthcare providers using the standard gamble technique.Main Outcome Measures and Results: The overall cost per quality-adjusted life-year (QALY) gained for rhIGF-I therapy compared with placebo was $US67,440. For the subgroups of patients who were progressing rapidly or were in earlier stages of disease at enrolment, rhIGF-I cost $US52,823 and $US43,197 per QALY gained, respectively.Conclusions: Treatment with rhIGF-I is most cost effective in ALS patients who are either in earlier stages of the disease or progressing rapidly. The cost effectiveness of rhIGF-I therapy compares favourably with treatments for other chronic progressive diseases.


Related Articles

  • Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing. Wong, Carlos K H; Lam, Cindy L K; Wan, Y F; Fong, Daniel Y T // BMC Cancer;2015, Vol. 15 Issue 1, p705 

    Background: The aim of this study was to evaluate the cost-effectiveness of CRC screening strategies from the healthcare service provider perspective based on Chinese population.Methods: A Markov model was constructed to compare the cost-effectiveness of recommended...

  • Effect of Using the HEART Score in Patients With Chest Pain in the Emergency Department: A Stepped-Wedge, Cluster Randomized Trial. Poldervaart, Judith M.; Reitsma, Johannes B.; Backus, Barbra E.; Koffijberg, Hendrik; Veldkamp, Rolf F.; ten Haaf, Monique E.; Appelman, Yolande; Mannaerts, Herman F. J.; van Dantzig, Jan-Melle; van den Heuvel, Madelon; el Farissi, Mohamed; Rensing, Bernard J. W. M.; Ernst, Nicolette M. S. K. J.; Dekker, Ineke M. C.; den Hartog, Frank R.; Oosterhof, Thomas; Lagerweij, Ghizelda R.; Buijs, Eugene M.; van Hessen, Maarten W. J.; Landman, Marcel A. J. // Annals of Internal Medicine;5/16/2017, Vol. 166 Issue 10, Following p689 

    Background: The HEART (History, Electrocardiogram, Age, Risk factors, and initial Troponin) score is an easy-to-apply instrument to stratify patients with chest pain according to their short-term risk for major adverse cardiac events (MACEs), but its effect on daily practice is...

  • Safety and efficacy of interferon retreatment in children with chronic hepatitis B. Ballauff, A.; Schneider, T.; Gerner, P.; Habermehl, P.; Behrens, R.; Wirth, S. // European Journal of Pediatrics;1998, Vol. 157 Issue 5, p382 

    Unlabelled: More than 50% of children with chronic hepatitis B do not respond to treatment with alpha-interferon. Since these patients continue to display high viral replication and progressive liver disease, retreatment should be considered. To date it has not been well evaluated...

  • The Effects of Combination of Robot-Assisted Therapy With Task-Specific or Impairment-Oriented Training on Motor Function and Quality of Life in Chronic Stroke. Hung, Chung-shan; Hsieh, Yu-wei; Wu, Ching-yi; Lin, Yi-ting; Lin, Keh-chung; Chen, Chia-ling // PM & R: Journal of Injury, Function & Rehabilitation;Aug2016, Vol. 8 Issue 8, p721 

    Background: Robot-assisted therapy (RT) is a promising intervention for stroke rehabilitation. RT hybridized with therapist-mediated therapy (eg, RT plus task-specific or impairment-oriented training) may possibly yield functionally relevant improvements. A comparative study of the...

  • Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study. Lee, Su Jin; Kim, Sungmin; Kim, Moonjin; Lee, Jeeyun; Park, Yeon Hee; Im, Young-Hyuck; Park, Se Hoon // BMC Cancer;2015, Vol. 15 Issue 1, p693 

    Background: The aim of this study was to assess the efficacy and safety of a combination regimen of capecitabine plus cisplatin (CC) or capecitabine plus paclitaxel (CP) as a first-line treatment in patients with metastatic esophageal squamous cell carcinoma.Methods:...

  • Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. Gardenghi, Sara; Ramos, Pedro; Marongiu, Maria Franca; Melchiori, Luca; Breda, Laura; Guy, Ella; Muirhead, Kristen; Rao, Niva; Roy, Cindy N.; Andrews, Nancy C.; Nemeth, Elizabeta; Follenzi, Antonia; Xiuli An; Mohandas, Narla; Ginzburg, Yelena; Rachmilewitz, Eliezer A.; Giardina, Patricia J.; Grady, Robert W.; Rivella, Stefano; An, Xiuli // Journal of Clinical Investigation;Dec2010, Vol. 120 Issue 12, p4466 

    Excessive iron absorption is one of the main features of β-thalassemia and can lead to severe morbidity and mortality. Serial analyses of β-thalassemic mice indicate that while hemoglobin levels decrease over time, the concentration of iron in the liver, spleen, and kidneys markedly...

  • Cost-effectiveness of strategies to improve HIV testing and receipt of results: economic analysis of a randomized controlled trial. Sanders, Gillian D.; Anaya, Henry D.; Asch, Steven; Hoang, Tuyen; Golden, Joya F.; Bayoumi, Ahmed M.; Owens, Douglas K. // JGIM: Journal of General Internal Medicine;Jun2010, Vol. 25 Issue 6, p556 

    Background: The CDC recommends routine voluntary HIV testing of all patients 13-64 years of age. Despite this recommendation, HIV testing rates are low even among those at identifiable risk, and many patients do not return to receive their results.Objective: To examine...

  • Proteases: Unravelling the therapeutic activity of activated protein C. Flight, Monica Hoyos // Nature Reviews Drug Discovery;Jan2010, Vol. 9 Issue 1, p20 

    The article discusses the therapeutic effect of activated protein C (APC) in diseases such as amyotrophic lateral sclerosis (ALS) and sepsis. It notes that recombinant APC treats sepsis though its therapeutic activity is poorly understood. Study shows that the infusion of APC or antibodies...

  • In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. Sereti, Irini; Imamichi, Hiromi; Natarajan, Ven; Imamichi, Tomozumi; Ramchandani, Meena S.; Badralmaa, Yunden; Berg, Steve C.; Metcalf, Julia A.; Hahn, Barbara K.; Shen, Jean M.; Powers, April; Davey, Richard T.; Kovacs, Joseph A.; Shevach, Ethan M.; Lane, H. Clifford // Journal of Clinical Investigation;Jul2005, Vol. 115 Issue 7, p1839 

    Administration of IL-2 to HIV-infected patients leads to expansion of a unique subset of CD4CD45ROCD25 cells. In this study, the origin, clonality, and function of these cells were investigated. Analysis of TCR excision circles revealed that the CD4CD45ROCD25 cells were the product of peripheral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics